Siemens Healthineers (XTRA:SHL) agreed a partnership with World Athletics to provide on-site diagnostic technologies for endurance events, aimed at supporting athlete safety. The company also entered ...

As the overwhelming majority of its peers in diagnostic development significantly scale back their predicted earnings from COVID-19 tests for the rest of the year, Siemens Healthineers is moving in ...

Siemens' partnership with ViiV Healthcare will focus on clinical trials related to Celsentri/Selzentry® (maraviroc) — ViiV Healthcare's novel CCR5 co-receptor antagonist for the treatment of ...

BERKELEY, Calif.--(BUSINESS WIRE)--Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of diagnostics tests that, unlike a clinical ...

Siemens Healthineers agreed to acquire Novartis AG’s (NYSE:NVS) diagnostics arm for $223.5 million (200 million euros) in a deal meant to enhance its cancer treatments. Both companies confirmed the ...

What are blood gas tests, and when are they requested? The industry term ‘blood gas testing’ has come to mean the accurate measurement and reporting of a wide menu of blood parameters, all on a single ...

Please can you give a brief introduction to companion diagnostics? Companion diagnostics is critical in helping to pave the way for personalized medicine, in which the treatment is adapted and ...

TARRYTOWN, N.Y. & SOUTHAMPTON, England--(BUSINESS WIRE)--Siemens Medical Solutions Diagnostics (www.usa.siemens.com/medical) today announced the availability of its ...

Siemens Healthcare Diagnostics is partnering with Janssen Pharmaceutica in an effort to develop and commercialize a companion diagnostic test for an early-stage compound being developed by Janssen.

Dublin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- The "ASEAN Point of Care Diagnostics - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering. The ASEAN Point of Care ...

Siemens Healthineers on Monday flagged problems at its diagnostics business, while the German health technology company also toned down expectations from its Atellica blood and urine testing machines ...